Recombinant Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI101935

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2016-2027
Base Year	2019
Forecast Period	2020-2027
Historical Period	2016-2018
Unit	Value (USD billion)
Segmentation	By Type Subunit Live Attenuated
	By Route of Administration Parenteral Oral
	By Disease Indication Human Papillomavirus (HPV) Hepatitis B Rotavirus Herpes Zoster Meningococcal B Others
	By Distribution Channel Hospital & Retail Pharmacies Government Suppliers Others
	By Geography North America (U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) The Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)